Trial Profile
TRANSFUSION OF RED BLOOD CELLS, TRANEXAMIC ACID AND FIBRINOGEN CONCENTRATE FOR SEVERE TRAUMA HEMORRHAGE AT PRE-HOSPITAL PHASE OF CARE. A PILOT TRIAL
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2022
Price :
$35
*
At a glance
- Drugs Fibrinogen (Primary) ; Tranexamic acid
- Indications Haemorrhage
- Focus Therapeutic Use
- Acronyms PRETIC
- 21 Apr 2022 Status changed from recruiting to completed.
- 08 Oct 2018 New trial record